Sonita Lontoh
Sonita Lontoh's purchase track record
Sonita Lontoh has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 11/6/2023 | TBI | $101K | +3.6% | -17.0% | +18.7% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 27, 2026
TrueBlue (TBI) Gains on Energy and Data Center Outlook. TrueBlue is highlighted as a beneficiary of ongoing energy infrastructure projects and the expansion of data centers, according to a recent Seeking Alpha piece. The stock also rose about 7.9% in recent trading, reflecting investor interest in those themes. The move comes as the shares trade near the middle of their 52‑week range with an RSI close to 50, and the price is above a well‑tested support level around $3.83.
Transaction History
| RUN | ▼ Sell | Open Market | 7,500 | $90K | 6/11/2026 | View on chart |
| TBI | ▼ Sell | Open Market | 2,186 | $15K | 6/5/2026 | View on chart |
| TBI | ▲ Buy | Grant | 27,566 | $0 | 2/20/2026 | View on chart |
| RUN | ▲ Buy | Grant | 9,687 | $0 | 1/2/2026 | View on chart |
| TBI | ▲ Buy | Grant | 17,158 | $0 | 2/21/2025 | View on chart |
| RUN | ▲ Buy | Grant | 17,357 | $0 | 1/2/2025 | View on chart |
| TBI | ▲ Buy | Grant | 9,521 | $0 | 2/23/2024 | View on chart |
| RUN | ▲ Buy | Grant | 11,920 | $0 | 1/2/2024 | View on chart |
| TBI | ▲ Buy | Open Market | 8,000 | $101K | 11/6/2023 | View on chart |
| TBI | ▲ Buy | Grant | 6,741 | $0 | 2/3/2023 | View on chart |
| RUN | ▲ Buy | Grant | 5,839 | $0 | 1/3/2023 | View on chart |
| TBI | ▲ Buy | Grant | 4,956 | $0 | 2/4/2022 | View on chart |
| RUN | ▲ Buy | Grant | 4,162 | $0 | 1/3/2022 | View on chart |
| TBI | ▲ Buy | Grant | 977 | $0 | 11/1/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 12, 2026
Sunrun analysts lower price targets amid valuation debate
Citigroup, Barclays and Goldman Sachs all kept their coverage of Sunrun but reduced their price targets to $14, $12 and $11 respectively. A separate valuation estimate says the stock may be as much as 52% below its intrinsic value ahead of the upcoming Q3 earnings release. Yahoo reported unusual options activity that could reflect multimillion‑dollar positions. The mix of lower targets and potential undervaluation adds mixed signals for the stock.
Sunrun analysts lower price targets amid valuation debate. Citigroup, Barclays and Goldman Sachs all kept their coverage of Sunrun but reduced their price targets to $14, $12 and $11 respectively. A separate valuation estimate says the stock may be as much as 52% below its intrinsic value ahead of the upcoming Q3 earnings release. Yahoo reported unusual options activity that could reflect multimillion‑dollar positions. The mix of lower targets and potential undervaluation adds mixed signals for the stock.